Lam Research (NASDAQ:LRCX) Shares Down 2.9% Following Insider Selling

Lam Research Corporation (NASDAQ:LRCX) fell 2.9% on Tuesday after an insider sold shares in the company. The stock traded as low as $142.50 and last traded at $143.24. 12,695,556 shares were traded during trading, an increase of 7% from the average session volume of 11,850,141 shares. The stock had previously closed at $147.46.

Specifically, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Wall Street Analysts Forecast Growth

LRCX has been the topic of a number of research reports. Oppenheimer set a $200.00 price target on Lam Research and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Needham & Company LLC increased their target price on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Erste Group Bank initiated coverage on shares of Lam Research in a research note on Thursday, August 14th. They issued a “buy” rating for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $170.00 target price on shares of Lam Research in a research report on Thursday, October 23rd. Finally, B. Riley upped their price target on shares of Lam Research from $160.00 to $175.00 and gave the company a “buy” rating in a report on Monday, October 20th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.04.

Lam Research Stock Down 2.9%

The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The stock has a market cap of $179.91 billion, a price-to-earnings ratio of 31.55, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The firm’s 50-day moving average is $141.60 and its 200 day moving average is $110.47.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio is 22.91%.

Institutional Investors Weigh In On Lam Research

Several institutional investors and hedge funds have recently modified their holdings of LRCX. IMG Wealth Management Inc. acquired a new stake in Lam Research in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the 2nd quarter valued at about $27,000. Triumph Capital Management acquired a new stake in Lam Research during the third quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research during the 2nd quarter valued at approximately $29,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the 2nd quarter worth about $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.